Streetbeat News

Earnings

WULF

TeraWulf (NASDAQ:WULF) is set to release its latest quarterly earnings report on August 14, 2023. Analysts estimate an earnings per share (EPS) of $-0.02. The company's past performance shows a pattern of EPS misses followed by share price drops. However, the stock has seen a 36.01% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 3:02 pm

PDSB

PDS Biotechnology (NASDAQ:PDSB) is set to release its latest quarterly earnings report on August 14, 2023. Analysts estimate an earnings per share (EPS) of $-0.37. The company's past performance shows a pattern of share price changes following earnings reports. The company's shares were trading at $4.795 as of August 10, with a 52-week period showing a 17.7% decrease.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 3:01 pm

ONDS

Ondas Holdings (NASDAQ:ONDS) is set to release its latest quarterly earnings report on August 14, 2023. Analysts estimate an earnings per share (EPS) of $-0.20. The company's past performance shows a trend of missing EPS estimates and subsequent drops in share price. The stock is currently trading at $1.105, down 78.72% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 3:01 pm

ONCY

Oncolytics Biotech (NASDAQ:ONCY) is set to release its latest quarterly earnings report on August 14, 2023. Analysts estimate an earnings per share (EPS) of $-0.09. The company's past performance shows a mixed impact on the share price post-earnings release. The stock is currently trading at $2.12 and has seen a 57.52% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 3:01 pm

BWEN

Broadwind (NASDAQ:BWEN) is set to release its latest quarterly earnings report on Monday, 2023-08-14. Analysts estimate an earnings per share (EPS) of $0.04. The company's past performance shows it beat EPS by $0.12 last quarter, leading to a 13.43% increase in share price the next day. Broadwind's shares were trading at $3.2 as of August 10, with a 0.63% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 3:01 pm

ZVRA

Zevra Therapeutics (NASDAQ:ZVRA) is set to release its latest quarterly earnings report on Monday, 2023-08-14. Analysts estimate an earnings per share (EPS) of $-0.39. Last quarter, the company missed EPS by $0.11, which was followed by a 7.11% increase in the share price. Shares of Zevra Therapeutics were trading at $4.99 as of August 10, and over the last 52-week period, shares are down 15.32%.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 3:01 pm

IONQ

IonQ, Inc. (NYSE:IONQ) reported mixed Q2 financial results, with revenue of $5.5 million, beating the analyst consensus estimate of $4.35 million, but a loss of 22 cents per share, missing estimates of a loss of 13 cents per share. The company also reported a record $28 million in bookings. Craig-Hallum analyst Richard Shannon maintained IonQ with a Buy and raised the price target from $12 to $21. IonQ shares are trading up over 22% at $17.42.

Portfolio Pulse from Erica Kollmann

August 11, 2023 | 3:01 pm

IRIX

IRIDEX Corporation reported worse-than-expected Q2 financial results and issued FY23 revenue guidance below estimates, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

August 11, 2023 | 3:01 pm

GMDA

Gamida Cell (NASDAQ:GMDA) is set to release its latest quarterly earnings report on August 14, 2023. Analysts estimate an earnings per share (EPS) of $-0.18. The company's past performance shows a mixed impact on the share price post-earnings release. The stock is currently trading at $1.23, down 62.69% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 3:01 pm

GRCL

Gracell Biotechnologies (NASDAQ:GRCL) is set to release its latest quarterly earnings report on August 14, 2023. Analysts estimate an earnings per share (EPS) of $-0.37. The company's past performance shows a pattern of share price drops following earnings reports, despite beating EPS estimates. The company's shares were trading at $3.75 as of August 10, with a 13.44% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 3:01 pm